☆ April 23–24, 2026: Inner Mongolia QH Pharmaceutical Co., Ltd. successfully passed the re-inspection by the Local Veterinary GMP Authority and recently obtained the GMP Certificate.
☆ January 28–30, 2026: Jiangsu Univopharm Co., Ltd. (Formulations) successfully passed the quality audit conducted by a strategic European customer.
☆ December 23, 2025: A renowned Indian pharmaceutical company conducted an on-site GMP audit of Inner Mongolia QH Pharmaceutical Co., Ltd., which was successfully passed.
☆ December 4–5, 2025: Changzhou Yabang-QH Company passed the re-inspection by the Ministry of Agriculture.
☆ December 15, 2025: A renowned Kenyan pharmaceutical company conducted an on-site GMP audit of Inner Mongolia QH Pharmaceutical Co., Ltd., which was successfully passed.
☆ November 25–28, 2025: Changzhou Yabang-QH Pharmaceutical Co., Ltd. passed the on-site CDE inspection for the human-use drug Albendazole and the cGMP compliance inspection.
☆ October 29–30, 2025:Inner Mongolia QH Pharmaceutical Co., Ltd. successfully passed the GMP audit conducted by a renowned US pharmaceutical company.
☆ October 14, 2025: A renowned Saudi Arabian pharmaceutical company conducted a GMP audit of Inner Mongolia QH Pharmaceutical Co., Ltd., which was successfully passed.
☆ September 22–24, 2025: Jiangsu Univopharm Co., Ltd. (Formulations) successfully passed the AVPMA (Australian Pesticides and Veterinary Medicines Authority) inspection.
☆ September 22, 2025: A renowned Brazilian pharmaceutical company conducted an online GMP audit of Inner Mongolia QH Pharmaceutical Co., Ltd., which was successfully passed.
☆ May 9, 2025: A renowned Kenyan pharmaceutical company conducted a GMP audit of Inner Mongolia QH Pharmaceutical Co., Ltd., which was successfully passed.
☆ March 21, 2025: A renowned Spanish pharmaceutical company conducted a GMP audit of Inner Mongolia QH Pharmaceutical Co., Ltd., which was successfully passed.
☆ May 6–9, 2025: Changzhou Yabang-QH Pharmaceutical Co., Ltd. passed the re-certification inspection conducted by the Shanghai Audit Center of Quality Management System for the ISO 14001:2015 standard and the GB/T45001-2020/ISO45001:2018 standard.
☆ March 17–18, 2025: Changzhou Yabang-QH Pharmaceutical successfully passed the quality audit conducted by a strategic European customer.
☆ February 27, 2025: Changzhou Yabang-QH Pharmaceutical successfully passed a quality audit conducted by a European customer.
☆ January 21, 2025: Jiangsu Univopharm Co., Ltd. (Formulations) passed the quality audit conducted by a strategic US customer.
☆ January 20–22, 2025: Changzhou Yabang-QH Pharmaceutical successfully passed an on-site WHO inspection.
☆ December 27-28, 2023, the Veterinary Drug GMP Expert Inspection Panel of the Ministry of Agriculture conducted an on-site inspection and acceptance for new products at Changzhou Yabang-QH Pharmachem Co., Ltd., which was successfully passed.  
☆ November 6, 2023, Changzhou Yabang-QH Pharmachem Co., Ltd. was again awarded the title of "Jiangsu High-Tech Enterprise" by the Jiangsu Provincial Department of Science and Technology, Jiangsu Provincial Department of Finance, and Jiangsu Provincial Taxation Bureau of the State Taxation Administration.  
☆ August 9-11, 2023, the Veterinary Drug GMP Expert Inspection Panel of the Ministry of Agriculture conducted an on-site inspection and acceptance at Jiangsu Univopharm Co.,Ltd., which was successfully passed.  
☆ July 14, 2023, Mr. Zhu Jianmin, General Manager of Jiangsu Yabang-QH Pharmachem Co., Ltd., received the First Prize of the Gansu Provincial Science and Technology Progress Award for the project: "Creation and Industrialization of Animal-Specific APIs and Preparations".  
☆ April 2023, Changzhou Yabang-QH 4 patents have been authorized, till then the company totally has 32 patents.
☆ Dec. 30, 2022, Plant 2 in Changzhou site completed its upgrading innovation project with 20 million RMB investment.
☆ Dec. 22, 2022, the Univo Formulation Plant Project received its final acceptance of construction.
☆ Dec. 7，2022， Jiangsu Provincial Securities Regulatory Bureau inspected Changzhou Yabang-QH on its IPO coaching efficiency.
☆ Nov. 23，2022， news announced in the local government website, Changzhou Yabang-QH is one of the five firms as candidates of “Local District Head Quality Award”.
☆ Nova. 10, 2022, Jiangsu Quality Horizons Pharmtech Co., Ltd.(the group company）organized the annual general meeting of stockholders.
☆ Feb.15, 2022, Yabang-QH organized the kick off meeting on project of “Local District Head Quality Award”.
☆ Dec. 22, 2021, Jiangsu Quality Horizons Pharmtech Co., Ltd.(the group company）organized the annual general meeting of stockholders.
☆ Sep. 26, 2021, Yabang-QH organized the Foundation-stone-laying Ceremony for the Upgrading Innovation Project & Univo Pets Formulation Project.
☆ June 10, 2021, Inner Mongolia Quality Horizons Pharmaceutical Co., Ltd. successfully passed the New Vet cGMP inspection made by the expert group of the Ministry of Agriculture.
☆ March 23, 2021, the trial production plan of the second phase project of Inner Mongolia Quality Horizons Pharmaceutical Co., Ltd. was approved by the local expert group assessment meeting.
☆ Nov. 21, 2020, the local government “Changzhou Binjiang Economic Development Zone Management Committee” signed agreement with Yabang-QH on Yabang-QH Upgrading Innovation Project.
☆ July 2020，new site Inner Mongolia Quality Horizons Pharmaceutical Co., Ltd started production.
☆ June 11th of 2020, Changzhou Yabang-QH Pharmachem Co., Ltd was successfully passed the re-inspection conducted by Jiangsu Province Department of Agriculture and Rural Areas.
☆ May 20-23th of 2019, Changzhou Yabang-QH Pharmachem Co., Ltd. was inspected by WHO and the inspection result was positive.
☆ Early 2019, invested new site Inner Mongolia Quality Horizons Pharmaceutical Co., Ltd.
☆ 2016, Succeeded FDA GMP inspection.
☆ 2016, Succeeded Plant 1# and 3# WHO GMP second inspection.
☆ 2015，Succeeded Plant 1# and 3# EDQM GMP inspection.
☆ 2013, Succeeded Plant 1# and 3# WHO GMP inspection.
☆2013, Obtained Closantel Sodium CEP certificate.
☆ April 2012, Yabang-QH officially started the long term cooperation with its second strategic partner.
☆ Jan. 2011, Yabang-QH site passed China GMP reinspection;
☆ Sep. 2009, Yabang-QH site passed EDQM Mebendazole polymorph C CEP approval; In Oct. 2009, passed EDQM Flubendazole Polymorph B CEP Approval;
☆ March 2009, Yabang-QH was certified as "Key High-tech Enterprise of Sate Spark Program";
☆ Jan. 2008, Yabang-QH jointly founded Changzhou City Veterinary Engineering & Technology Center with the local government;
☆ In 2007-2010: Designed & constructed Plant 3# at Yabang-QH site
☆ In June 2007,Yabang-QH site passed the authentication on ISO14001 Environmental Protection Management System and OSHAS18001 EHS System.
☆ In December 2006,Yabang-QH site passed the second GMP inspection(additional products).
☆ On July 16, 2006, Yabang-QH jointly set up Changzhou City Veterinary Engineering & Technology Center with the local government, specializing in the R&D of Anthelmintic Products.
☆ In March 2006: set up Lianyungang City YahuiPharmachemCo., Ltd. in National Chemical Zone(for intermediates)
☆ November 2005: Yabang-QH site passed GMP inspection.
☆ January 2005: Entitled as a "Jiangsu Private Enterprise with Great Science & Technology Progress".
☆ April 2004: Set up Changzhou Yabang-QH Pharmachem Ltd. by investing in Jiangbian Industry Zone, occupying 93,300sqm.
☆ October 2002: Become one of the director member companies of China Animal Health Use Chemicals Association.
☆ October 2002: Listed as the "The Top Fifty Veterinary Enterprises in China".
☆ September 2002: Obtained ISO9001 Certificate issued by Lloyd's Register Quality Assurance UK.
☆ September 2002: Entitled as a "Hi-tech Enterprise in Jiangsu Province".
☆ March 2001: Set up Changzhou Yabang Veterinary Co., Ltd.
☆ September 1998: Obtained ISO9002 Certificate issued by Lloyd's Register Quality Assurance UK.
☆ June 1991: Started to manufacture Albendazole in Changzhou Synthesized Materials Factory.